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Supplementary Table S1 
Results From Gene Set Analysis for Significant Variants With Frequency <0.01 
 Obesity controls Depression controls 
 Gene Number of variants p-value Gene Number of variants p-value 
All variants    RP11-414H17.5 
RP11-118B18.1 
MESP2/SNORD113-9 
2 
2 
2 
1.34-6 
1.97-6 
5.51-6 
Nonsynonymous SYNGAP1 
 
3 
 
4.0-6 
 
 
SYNGAP1 
HOXD1/ HOXD-AS1 
CECR6 
AC022201.5 
CYP26C1  
ZNF703 
NFKBIL1 
2 
2 
2 
2 
2 
2 
3 
1.23-6 
8.82-7 
6.22-7 
1.04-5 
6.99-6 
5.75-7 
2.77-5 
Synonymous    C9orf66 
FAM110C  
ID4/ RP1-167F1.2 
TBC1 
2 
2 
2 
2 
1.92-8 
3.91-6 
9.91-6 
3.44-6 
 Note: Significant genes containing a single variant are not shown. Bold indicates common results across case-control subgroup analyses.  
Supplementary Table S2 
Results From Gene Set Analysis for Significant Variants With Frequency <0.05 
 Obesity controls Depression controls 
 Gene Number of variants p-value Gene Number of variants p-value 
All variants RP11-673E1.4/ GYPB 
/GYPA  
14  
/ 9 
2.74-12  
5.76-12 
RP11-673E1.4/GYPB 
/GYPA 
RP11-414H17.5 
RP11-118B18.1 
11  
/ 7 
2 
2 
9.94-7 
8.05-7 
1.16-6 
1.08-6 
Nonsynonymous RP11-673E1.4/ GYPB  
/GYPA 
  
6  
/ 2 
 
4.35-12 
5.17-12 
 
RP11-673E1.4/ GYPB 
/GYPA 
CECR6 
FAM136A/AC022201.5  
ZNF703   
5  
/ 2 
2 
2 
2 
2.85-7 
2.4-7 
4.41-8 
4.62-6 
7.40-7 
Synonymous    SOX17  
FAM110C  
ID4/RP1-167F1.2 
2 
2 
2 
2.61-7 
4.16-6 
9.35-6 
Note: Significant genes containing a single variant are not shown. Bold indicates common results across case-control subgroup analyses. 
  
Supplementary Table S3 
Significant Gene Ontology Pathways Enriched in the Varying Analyses Comprising the Depression Controls  
 
 
Note: p-value, FDR corrected p-value, enrichment values, and prominent genes in each pathway are listed. 
SNV: Single nucleotide variants* Enrichment is defined as (b/n)/(B/N) [N: Total number of genes; B: Total number of genes associated with a specific GO term,  
n: Number of genes in the ‘target set’, b: Number of genes in the ‘target set’ associated with a specific GO term].  
 
 Gene ontology p-value FDR p-value Enrichment values* Genes in pathway 
Synonymous      
SNVs<.01      
Molecular Function 
GO:0008376 
acetylgalactosaminyl
transferase activity 
1.23E-5 .03 5.63 (6764,18,667,10) GALNT6 — udp-n-acetyl-alpha-d-galactosamine:polypeptide n-
acetylgalactosaminyltransferase 6 (galnac-t6) 
GALNT12 — udp-n-acetyl-alpha-d-galactosamine:polypeptide n-
acetylgalactosaminyltransferase 12 (galnac-t12) 
GALNT10 — udp-n-acetyl-alpha-d-galactosamine:polypeptide n-
acetylgalactosaminyltransferase 10 (galnac-t10) 
B4GALNT3 — beta-1,4-n-acetyl-galactosaminyl transferase 3 
GALNT18 — udp-n-acetyl-alpha-d-galactosamine:polypeptide n-
acetylgalactosaminyltransferase 18 
GALNT3 — udp-n-acetyl-alpha-d-galactosamine:polypeptide n-
acetylgalactosaminyltransferase 3 (galnac-t3) 
GALNT2 — udp-n-acetyl-alpha-d-galactosamine:polypeptide n-
acetylgalactosaminyltransferase 2 (galnac-t2) 
CHPF — chondroitin polymerizing factor 
B3GALNT2 — beta-1,3-n-acetylgalactosaminyltransferase 2 
B4GALNT4 — beta-1,4-n-acetyl-galactosaminyl transferase 4 
